ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Edward L. Bove
Ralph S. Mosca
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maher, K. O.
Right arrow Articles by Kulik, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maher, K. O.
Right arrow Articles by Kulik, T. J.
Related Collections
Right arrow Cardiac - other

Ann Thorac Surg 2002;74:1195-1200
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

A retrospective review of three antibiotic prophylaxis regimens for pediatric cardiac surgical patients

Kevin O. Maher, MDa*, Kristen VanDerElzen, MPHb, Edward L. Bove, MDc, Ralph S. Mosca, MDc, Carol E. Chenoweth, MDb, Thomas J. Kulik, MDa

a Division of Pediatric Cardiology, University of Michigan Medical Center, and Michigan Congenital Heart Center, Ann Arbor, Michigan, USA
b Division of Infection Control and Epidemiology, University of Michigan Medical Center, and Michigan Congenital Heart Center, Ann Arbor, Michigan, USA
c Division of Cardiac Surgery, University of Michigan Medical Center, and Michigan Congenital Heart Center, Ann Arbor, Michigan, USA

Accepted for publication June 13, 2002.

* Address reprint requests to Dr Maher, Department of Cardiology, Connecticut Children’s Medical Center, 282 Washington St, Hartford, CT, USA 06106.
e-mail: kmaher{at}nemours.org

BACKGROUND: Optimal antimicrobial prophylaxis for the pediatric cardiac surgical patient is unknown. We have reviewed our experience with more than 4,000 pediatric cardiac surgical patients at the University of Michigan to evaluate antibiotic prophylaxis regimens.

METHODS: Three antibiotic prophylaxis protocols were serially used during a 6-year period: Protocol 1 (n = 786): cefazolin was administered before operation and continued as long as thoracostomy tubes or central venous catheters were present; Protocol 2 (n = 1095): cefazolin was discontinued 48 hours postoperatively, regardless of the presence of tubes or catheters; Protocol 3 (n = 2039): cefazolin was continued as long as thoracostomy tubes were present, but not for central venous catheters. Patients with an open chest postoperatively received vancomycin and gentamicin until chest closure. This was identical during all three protocols. We retrospectively determined the rate of surgical site infections and unrelated bloodstream infections (the latter for both cardiac medical and surgical patients) for the three protocols.

RESULTS: Surgical site infections per 100 operations for protocols 1, 2, and 3 was 2.04, 6.58, and 1.67, respectively (p < 0.05 for protocol 2 versus protocols 1 and 3). The mean age of patients with a surgical site infection ranged from 12 to 15.4 months. Patients with an open chest had a higher rate of surgical site infection (18.8% for protocol 2 and 9.3% for protocol 3). Bloodstream infections per 1,000 patient days for protocols 1, 2, and 3 were 2.18, 6.51, and 5.02, respectively (p < 0.05 protocol 1 versus protocols 2 and 3).

CONCLUSIONS: These data suggest that pediatric cardiac surgical patients may benefit from prophylactic antibiotics as long as thoracostomy tubes are in place.




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
C. A. Knoderer, E. G. Cox, M. D. Berg, A. H. Webster, and M. W. Turrentine
Efficacy of limited cefuroxime prophylaxis in pediatric patients after cardiovascular surgery
Am. J. Health Syst. Pharm., May 15, 2011; 68(10): 909 - 914.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Das, A. Rubio, J. M. Simsic, P. M. Kirshbom, B. Kogon, K. R. Kanter, and K. Maher
Bloodstream Infections Increased After Delayed Sternal Closure: Cause or Coincidence
Ann. Thorac. Surg., March 1, 2011; 91(3): 793 - 797.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. S. Woodward, M. Son, J. Calhoon, J. Michalek, and S. A. Husain
Sternal Wound Infections in Pediatric Congenital Cardiac Surgery: A Survey of Incidence and Preventative Practice
Ann. Thorac. Surg., March 1, 2011; 91(3): 799 - 804.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Costello, D. A. Graham, D. F. Morrow, J. Morrow, G. Potter-Bynoe, T. J. Sandora, F. A. Pigula, and P. C. Laussen
Risk Factors for Surgical Site Infection After Cardiac Surgery in Children
Ann. Thorac. Surg., June 1, 2010; 89(6): 1833 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
C. A. Knoderer, E. M. Anderson, and E. G. Cox
Survey of congenital heart surgeons' preferences for antimicrobial prophylaxis for pediatric cardiac surgery patients
Am. J. Health Syst. Pharm., November 1, 2008; 65(21): 2008 - 2010.
[Full Text] [PDF]


Home page
HeartHome page
K. Dhadwal, S. Al-Ruzzeh, T. Athanasiou, M. Choudhury, P. Tekkis, P. Vuddamalay, H. Lyster, M. Amrani, and S. George
Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial
Heart, September 1, 2007; 93(9): 1126 - 1133.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.